OnCore Login

Sponsor-Investigators

Darren R. Carpizo

HCRN-GI16-288

A Phase II Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Resectable Hepatic-Limited Metastatic Colorectal Cancer HCRN: GI16-288
Status
Open to Accrual
Cancer Types
Colorectal
Locations
Cleveland Clinic Cancer Center, Florida, Kansas, Knight Cancer Institute at Oregon Health & Science University, New Jersey, Ohio, Oregon, Rutgers Cancer Institute of New Jersey, Sylvester Comprehensive Cancer Center at the University of Miami, The Ohio State University, University of Kansas Medical Center
Read more

BTCRC-GI20-457

A Phase II study of Atezolizumab and Bevacizumab in Child-Pugh B7 Hepatocellular Carcinoma (The AB7 Trial) Big Ten Cancer Research Consortium BTCRC-GI20-457
Status
Open to Accrual
Cancer Types
Liver and Bile Duct
Locations
DHR Health, Fred & Pamela Buffett Cancer Center, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, New York University Cancer Institute, Rutgers Cancer Institute of New Jersey, University of Illinois Cancer Center, University of Wisconsin Carbone Cancer Center
Read more
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278